K
Krystal Biotech, Inc. (KRYS)
NMS – Real Time Price. Currency in USD
372.25
+12.32 (3.42%)
At close: Jun 26, 2026, 4:00 PM EDT
371.50
-0.75 (-0.20%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
372.25
+12.32 (3.42%)
At close: Jun 26, 2026, 4:00 PM EDT
371.50
-0.75 (-0.20%)
After-hours: Jun 26, 2026, 7:37 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $501.3M significantly exceed its total debt $9.1M, ensuring strong financial flexibility
Total current assets $1.0B exceed Total current liabilities $107.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $73.2M, supporting its financial health
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.46 | 6.05 | 10 | |
| Quick ratio | 9.06 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 10 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 51M | 291M | 389M | 417M |
| Gross Profit | -4M | 43M | 264M | 360M | 387M |
| Operating Income | -120M | -97M | 103M | 161M | 179M |
| Net Income | -140M | 11M | 89M | 205M | 225M |
| EBITDA | -116M | -92M | 110M | 168M | 185M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 28.93 | 36.93 | 10 |
| Next quarter | 37.32 | -25.97 | 5.5 |
| Current year | 33.42 | 12.2 | 8.5 |
| Next year | 27.04 | 26.49 | 10 |
| Weighted average score | 8.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 8.64 | 8.82 | 7.65 | -2.82 | 4.8 |
| Y/Y | 31.95 | 56.53 | 52.5 | 195.72 | 10 |
| 3y average | 501.99 | 317.71 | 301.44 | 103.82 | 10 |
| 5y average | 700.79 | 147.13 | 149.18 | 19.06 | 9.8 |
| Weighted average score | 8.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 9.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Wide | 8.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 4.0 |
| Weighted average score | 6.0 | |